ApoVax careers

ApoVax, Inc. is based on the work of Haval Shirwan, Ph.D. at the University of Louisville.

ApoVax104, an immunostimulatory adjuvant construct, consists of streptavidin fused to the costimulatory molecule 4-1BBL. It is well differentiated from other adjuvants. ApoVax104 can be mixed with or conjugated to any biotinylated antigen (or peptide)--cancer or infectious disease.

ApoVax is also developing ApoFasL—a means of immunomodulation for tolerance induction—for the treatment of Type 1 diabetes.